CXCR5 CAR-T cells simultaneously target B cell non-Hodgkin’s lymphoma and tumor-supportive follicular T helper cells
CAR-T cell therapy targeting CD19 is not as efficient to treat lymphoma with nodal dissemination as it is for B cell leukaemia. Here, the authors generate CAR-T cells against CXCR5 and show they inhibit tumour growth by depleting both B and follicular T helper cells in lymphoma models.
Guardado en:
Autores principales: | Mario Bunse, Janina Pfeilschifter, Julia Bluhm, Maria Zschummel, Jara J. Joedicke, Anthea Wirges, Helen Stark, Vivien Kretschmer, Markus Chmielewski, Wolfgang Uckert, Hinrich Abken, Jörg Westermann, Armin Rehm, Uta E. Höpken |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/ec898a29a91e4a4fa35537b32be47016 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
CXCR5+PD-1+ follicular helper CD8 T cells control B cell tolerance
por: Yuhong Chen, et al.
Publicado: (2019) -
The Role of T Follicular Helper Cells and T Follicular Regulatory Cells in the Pathogenesis of Autoimmune Hemolytic Anemia
por: Yuhan Gao, et al.
Publicado: (2019) -
T follicular helper and T follicular regulatory cells have different TCR specificity
por: Ana Raquel Maceiras, et al.
Publicado: (2017) -
The frequency of follicular T helper cells differs in acute and chronic neuroinflammation
por: Adalie Baniahmad, et al.
Publicado: (2020) -
γδ T cells control humoral immune response by inducing T follicular helper cell differentiation
por: Rafael M. Rezende, et al.
Publicado: (2018)